Invizyne Technologies Announces Closing of Initial Public Offering
November 14, 2024 16:05 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing
November 13, 2024 16:05 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce...
Invizyne Technologies Begins Trading on NASDAQ
November 13, 2024 09:05 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024
November 12, 2024 10:52 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
Invizyne Technologies Announces Pricing of $15 Million Initial Public Offering
November 11, 2024 16:05 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
May 07, 2024 13:52 ET
|
Invizyne Technologies, Inc.
Michael Heltzen appointed as CEO bringing 20 years of global commercial leadership experience and a track record of successful launches and exits Additional industry veterans join in...
Invizyne Technologies Announces Filing of Registration Statement for Proposed Offering and Listing on Nasdaq
February 12, 2024 08:00 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC,...
Michael Burns Joins Invizyne as Executive Vice President of Energy Transition
November 08, 2023 16:05 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC,...
Invizyne Selected by Shell GameChanger Accelerator Powered by NREL for Sixth Cohort
October 17, 2023 10:00 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC,...
Invizyne Awarded Additional $3.77 Million Grant from U.S. Department of Energy
October 11, 2023 11:10 ET
|
Invizyne Technologies, Inc.
Monrovia, CA, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a “Big Idea” company from MDB Capital Holdings, LLC,...